Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kocisko, David A.
30  Ergebnisse:
Personensuche X
?
1

Evaluation of exogenous siRNA addition as a metabolic engin..:

Tummala, Seshu ; Titus, Michael ; Wilson, Lee...
Biotechnology Progress.  29 (2013)  2 - p. 415-424 , 2013
Link: https://doi.org/10.1002/..
 
?
2

Discovery of 4-aminomethylphenylacetic acids as γ-secretase..:

Xin, Zhili ; Peng, Hairuo ; Zhang, Andrew...
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  24 - p. 7277-7280 , 2011
Link: https://doi.org/10.1016/..
 
?
3

Identification of prion inhibitors by a fluorescence-polari..:

Kocisko, David A. ; Bertholet, Nadine ; Moore, Roger A...
Analytical Biochemistry.  363 (2007)  1 - p. 154-156 , 2007
Link: https://doi.org/10.1016/..
 
?
4

Octapeptide repeat insertions increase the rate of protease..:

Moore, Roger A. ; Herzog, Christian ; Errett, John...
Protein Science.  15 (2006)  3 - p. 609-619 , 2006
Link: https://doi.org/10.1110/..
 
?
5

Comparison of protease-resistant prion protein inhibitors i..:

Kocisko, David A. ; Engel, Abbi L. ; Harbuck, Kristin...
Neuroscience Letters.  388 (2005)  2 - p. 106-111 , 2005
Link: https://doi.org/10.1016/..
 
?
6

Evaluation of new cell culture inhibitors of protease-resis..:

Kocisko, David A. ; Morrey, John D. ; Race, Richard E...
Journal of General Virology.  85 (2004)  8 - p. 2479-2483 , 2004
Link: https://doi.org/10.1099/..
 
?
7

S3-02-03 Prion protein conversions and TSE infections:

Caughey, Byron ; Baron, Gerald S. ; Magalhaes, Ana Cristina..
Neurobiology of Aging.  25 (2004)  - p. S47 , 2004
Link: https://doi.org/10.1016/..
 
?
8

A nucleic-acid accomplice?:

Caughey, Byron ; Kocisko, David A.
Nature.  425 (2003)  6959 - p. 673-674 , 2003
Link: https://doi.org/10.1038/..
 
?
9

Plasma Concentrations of Tafenoquine, a New Long-Acting Ant..:

Michael D. Edstein ; Kocisko, David A. ; Douglas S. Walsh...
Clinical Infectious Diseases.  37 (2003)  12 - p. 1654-1658 , 2003
Link: https://www.jstor.org/st..
 
?
10

Population pharmacokinetics of the new antimalarial agent t..:

Edstein, Michael D. ; Kocisko, David A. ; Brewer, Thomas G....
British Journal of Clinical Pharmacology.  52 (2001)  6 - p. 663-670 , 2001
Link: https://doi.org/10.1046/..
 
?
11

Measurement of Tafenoquine (WR 238605) in Human Plasma and ..:

Kocisko, David A. ; Walsh, Douglas S. ; Eamsila, Chirapa.
Therapeutic Drug Monitoring.  22 (2000)  2 - p. 184-189 , 2000
Link: https://doi.org/10.1097/..
 
?
12

Methods for Studying Prion Protein (PrP) Metabolism and the..:

Caughey, Byron ; Raymond, Gregory J. ; Priola, Suzette A....
Molecular Biotechnology.  13 (1999)  1 - p. 45-56 , 1999
Link: https://doi.org/10.1385/..
 
?
13

Molecular assessment of the potential transmissibilities of..:

Raymond, Gregory J. ; Hope, James ; Kocisko, David A....
Nature.  388 (1997)  6639 - p. 285-288 , 1997
Link: https://doi.org/10.1038/..
 
?
14

Partial Unfolding and Refolding of Scrapie-Associated Prion..:

Kocisko, David A. ; Lansbury,, Peter T. ; Caughey, Byron
Biochemistry.  35 (1996)  41 - p. 13434-13442 , 1996
Link: https://doi.org/10.1021/..
 
?
15

Non-genetic propagation of strain-specific properties of sc..:

Bessen, Richard A. ; Kocisko, David A. ; Raymond, Gregory J....
Nature.  375 (1995)  6533 - p. 698-700 , 1995
Link: https://doi.org/10.1038/..
 
1-15